dCBP-1 is a chemical degrader of p300/CBP. dCBP-1 hijacks the E3 ubiquitin ligase CRBN for selective degradation of p300/CBP. Degradation of p300/CBP by dCBP-1 leads to effective multiple myeloma cell killing.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 154 | |
2 mg | In stock | $ 261 | |
4 mg | In stock | $ 467 | |
10 mg | In stock | $ 762 | |
20 mg | In stock | $ 1196 |
Description | dCBP-1 is a chemical degrader of p300/CBP. dCBP-1 hijacks the E3 ubiquitin ligase CRBN for selective degradation of p300/CBP. Degradation of p300/CBP by dCBP-1 leads to effective multiple myeloma cell killing. |
In vitro | Treatment of the human haploid cell line HAP1 for 6 h with dCBP-1 revealed almost complete loss of both CBP and p300 between 10 and 1,000 nM doses. A time course analysis with 250 nM dCBP-1 revealed almost complete degradation of p300/CBP within an hour of treatment. dCBP-1 was also able to induce near-complete p300/CBP degradation across other multiple myeloma cell lines tested, including MM1R, KMS-12-BM, and KMS34. |
CAS No. | 2484739-25-3 |
Chemical Formula | C51H63F2N11O10 |
Molecular Weight | 1028.11 |
Solubility | DMSO: 50 mg/mL (48.63 mM) |
Storage | Powder: -20°C for 2 years In solvent: -80°C for 1 year |
bottom